Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029103600> ?p ?o ?g. }
- W2029103600 endingPage "476" @default.
- W2029103600 startingPage "472" @default.
- W2029103600 abstract "Because of their susceptibility to pneumococcal sepsis, children with sickle cell disease and fever are usually hospitalized for antibiotic therapy. Outpatient treatment may be a safe and less expensive alternative for selected patients.After evaluation in the emergency room, children ranging from 6 months to 12 years of age who had sickle hemoglobinopathies and temperatures exceeding 38.5 degrees C were randomly assigned to treatment as either inpatients or outpatients. We excluded from randomization children at higher risk of sepsis (as defined by specific criteria, including temperature above 40 degrees C, white-cell count below 5000 per cubic millimeter or above 30,000 per cubic millimeter, and the presence of pulmonary infiltrates) or with complications of sickle cell disease (such as a hemoglobin level below 5 g per deciliter, dehydration, or severe pain); these children were treated as inpatients. All patients received an initial intravenous dose of ceftriaxone (50 mg per kilogram of body weight). Those treated as outpatients returned 24 hours later for a second dose of ceftriaxone, whereas the in patients were treated as directed by their physicians.None of the 86 patients (with a total of 98 febrile episodes) in the randomized groups had sepsis, as compared with 6 of the 70 patients (7 of 86 episodes) excluded because of higher risk (P = 0.004). Among the 44 children (50 episodes) assigned to outpatient treatment, there were 11 hospitalizations (22 percent of episodes) within two weeks after treatment (95 percent confidence interval, 12 to 36 percent), whereas after inpatient care only a single patient (2 percent of episodes) was rehospitalized. When the randomized groups were compared, outpatient treatment saved a mean of $1,195 per febrile episode. The median hospital stay was 3 days (range, 1 to 6) for the children randomly assigned to inpatient care and 4 days (range, 1 to 18) for the higher-risk children treated as inpatients (P < 0.001).With the use of conservative eligibility criteria, at least half the febrile episodes in children with sickle cell disease can be treated safely on an outpatient basis, with substantial reductions in cost." @default.
- W2029103600 created "2016-06-24" @default.
- W2029103600 creator A5001311437 @default.
- W2029103600 creator A5003974074 @default.
- W2029103600 creator A5011975513 @default.
- W2029103600 creator A5021601386 @default.
- W2029103600 creator A5033944275 @default.
- W2029103600 creator A5046180840 @default.
- W2029103600 creator A5046552829 @default.
- W2029103600 creator A5053790193 @default.
- W2029103600 creator A5074132822 @default.
- W2029103600 creator A5089403407 @default.
- W2029103600 date "1993-08-12" @default.
- W2029103600 modified "2023-09-26" @default.
- W2029103600 title "A Randomized Study of Outpatient Treatment with Ceftriaxone for Selected Febrile Children with Sickle Cell Disease" @default.
- W2029103600 cites W1547825094 @default.
- W2029103600 cites W1924485950 @default.
- W2029103600 cites W1974762589 @default.
- W2029103600 cites W2003511841 @default.
- W2029103600 cites W2018107430 @default.
- W2029103600 cites W2053184918 @default.
- W2029103600 cites W2094278115 @default.
- W2029103600 cites W2151338876 @default.
- W2029103600 cites W4231803579 @default.
- W2029103600 cites W4232827429 @default.
- W2029103600 cites W4293174344 @default.
- W2029103600 doi "https://doi.org/10.1056/nejm199308123290705" @default.
- W2029103600 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8332152" @default.
- W2029103600 hasPublicationYear "1993" @default.
- W2029103600 type Work @default.
- W2029103600 sameAs 2029103600 @default.
- W2029103600 citedByCount "82" @default.
- W2029103600 countsByYear W20291036002012 @default.
- W2029103600 countsByYear W20291036002013 @default.
- W2029103600 countsByYear W20291036002014 @default.
- W2029103600 countsByYear W20291036002015 @default.
- W2029103600 countsByYear W20291036002016 @default.
- W2029103600 countsByYear W20291036002017 @default.
- W2029103600 countsByYear W20291036002018 @default.
- W2029103600 countsByYear W20291036002019 @default.
- W2029103600 countsByYear W20291036002020 @default.
- W2029103600 countsByYear W20291036002021 @default.
- W2029103600 countsByYear W20291036002022 @default.
- W2029103600 countsByYear W20291036002023 @default.
- W2029103600 crossrefType "journal-article" @default.
- W2029103600 hasAuthorship W2029103600A5001311437 @default.
- W2029103600 hasAuthorship W2029103600A5003974074 @default.
- W2029103600 hasAuthorship W2029103600A5011975513 @default.
- W2029103600 hasAuthorship W2029103600A5021601386 @default.
- W2029103600 hasAuthorship W2029103600A5033944275 @default.
- W2029103600 hasAuthorship W2029103600A5046180840 @default.
- W2029103600 hasAuthorship W2029103600A5046552829 @default.
- W2029103600 hasAuthorship W2029103600A5053790193 @default.
- W2029103600 hasAuthorship W2029103600A5074132822 @default.
- W2029103600 hasAuthorship W2029103600A5089403407 @default.
- W2029103600 hasBestOaLocation W20291036001 @default.
- W2029103600 hasConcept C126322002 @default.
- W2029103600 hasConcept C141071460 @default.
- W2029103600 hasConcept C168563851 @default.
- W2029103600 hasConcept C187212893 @default.
- W2029103600 hasConcept C204243189 @default.
- W2029103600 hasConcept C2776520383 @default.
- W2029103600 hasConcept C2778384902 @default.
- W2029103600 hasConcept C2778620579 @default.
- W2029103600 hasConcept C2779134260 @default.
- W2029103600 hasConcept C2780976302 @default.
- W2029103600 hasConcept C44249647 @default.
- W2029103600 hasConcept C501593827 @default.
- W2029103600 hasConcept C71924100 @default.
- W2029103600 hasConcept C86803240 @default.
- W2029103600 hasConcept C89423630 @default.
- W2029103600 hasConceptScore W2029103600C126322002 @default.
- W2029103600 hasConceptScore W2029103600C141071460 @default.
- W2029103600 hasConceptScore W2029103600C168563851 @default.
- W2029103600 hasConceptScore W2029103600C187212893 @default.
- W2029103600 hasConceptScore W2029103600C204243189 @default.
- W2029103600 hasConceptScore W2029103600C2776520383 @default.
- W2029103600 hasConceptScore W2029103600C2778384902 @default.
- W2029103600 hasConceptScore W2029103600C2778620579 @default.
- W2029103600 hasConceptScore W2029103600C2779134260 @default.
- W2029103600 hasConceptScore W2029103600C2780976302 @default.
- W2029103600 hasConceptScore W2029103600C44249647 @default.
- W2029103600 hasConceptScore W2029103600C501593827 @default.
- W2029103600 hasConceptScore W2029103600C71924100 @default.
- W2029103600 hasConceptScore W2029103600C86803240 @default.
- W2029103600 hasConceptScore W2029103600C89423630 @default.
- W2029103600 hasIssue "7" @default.
- W2029103600 hasLocation W20291036001 @default.
- W2029103600 hasLocation W20291036002 @default.
- W2029103600 hasOpenAccess W2029103600 @default.
- W2029103600 hasPrimaryLocation W20291036001 @default.
- W2029103600 hasRelatedWork W2051711579 @default.
- W2029103600 hasRelatedWork W2088544186 @default.
- W2029103600 hasRelatedWork W242090125 @default.
- W2029103600 hasRelatedWork W2539600999 @default.
- W2029103600 hasRelatedWork W2588514944 @default.
- W2029103600 hasRelatedWork W2754302395 @default.
- W2029103600 hasRelatedWork W2785286218 @default.